FDA updates talazoparib and enzalutamide labeling, confirming survival benefits for HRR-mutated mCRPC, while excluding ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Christopher Gregg has lived years beyond what his oncologists originally accepted. Lessons from farming may have helped.

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...

Standing at just 5 feet 1 inch tall, Carol Johnson-Cromer is a force of nature, radiating energy, resilience, and an ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Former President Joe Biden has been diagnosed with prostate cancer. Biden, 82, was diagnosed Friday, May 16, with prostate ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Amplia Therapeutics has reported a 'complete response' from a patient with metastasised pancreatic cancer: "A rare event".

During a live event, Ahmad Tarhini, MD, PhD, and participants discussed how to use combination immunotherapy in patients with ...

While less than 1% of cancer patients refuse conventional therapy, some choose alternative care, which can have dire ...